{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T07:45:24Z","timestamp":1776584724802,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008050","name":"Fundaci\u00f3n Cellex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008978","name":"Philips Oral Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijrobp.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:40:16Z","timestamp":1591922416000},"page":"1047-1054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial"],"prefix":"10.1016","volume":"108","author":[{"given":"Maud","family":"Jaccard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e8le","family":"Dubouloz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Escude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Jorcano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Linthout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Bral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilko","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bruynzeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Minn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lev","family":"Tsvang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvi","family":"Symon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Lencart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ufuk","family":"Abacioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Mar\u00eda","family":"P\u00e9rez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Miralbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.06.002_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the hypo-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiation therapy for localized prostate cancer: A systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (pace-b): Acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib4","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/cam4.2966","article-title":"Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results","volume":"9","author":"Zilli","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0360-3016(02)03790-2","article-title":"Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas","volume":"55","author":"Khalil","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2012.08.008","article-title":"QA makes a clinical trial stronger: Evidence-based medicine in radiation therapy","volume":"105","author":"Weber","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2011.05.073","article-title":"Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting","volume":"100","author":"Weber","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0959-8049(99)00336-6","article-title":"Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer","volume":"36","author":"Bentzen","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1754-9485.12025","article-title":"Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 \u2018radar\u2019 trial","volume":"57","author":"Kearvell","year":"2013","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2007.07.001","article-title":"Quality assurance of dosimetry and the impact on sample size in randomized clinical trials","volume":"86","author":"Pettersen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib11","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1200\/JCO.2009.21.8529","article-title":"Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411","volume":"27","author":"Crane","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib12","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1200\/JCO.2001.19.11.2905","article-title":"Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin\u2019s disease: Long-term results of a randomized trial of radiotherapy alone","volume":"19","author":"D\u00fchmke","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2010.11.039","article-title":"Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704\u2014A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas","volume":"82","author":"Abrams","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib14","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0360-3016(94)90011-6","article-title":"Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer","volume":"30","author":"Diaz","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib17","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A radiation therapy oncology group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib18","article-title":"The international commission on radiation units and measurements","volume":"10","year":"2016","journal-title":"J ICRU"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2307\/1932409","article-title":"Measures of the amount of ecologic association between species","volume":"26","author":"Dice","year":"1945","journal-title":"Ecology"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jnci\/djt001","article-title":"Radiotherapy protocol deviations and clinical outcomes: A meta-analysis of cooperative group clinical trials","volume":"105","author":"Ohri","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2015.01.046","article-title":"Quantifying unnecessary normal tissue complication risks due to suboptimal planning: A secondary study of RTOG 0126","volume":"92","author":"Moore","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0959-8049(01)00440-3","article-title":"EORTC radiotherapy group: Achievements and future projects","volume":"38","author":"Budach","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fonc.2013.00031","article-title":"Future vision for the quality assurance of oncology clinical trials","volume":"3","author":"Fitzgerald","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2014.03.023","article-title":"Radiation therapy quality assurance in clinical trials\u2014Global harmonisation group","volume":"111","author":"Melidis","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijrobp.2014.03.012","article-title":"Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2019.07.018","article-title":"Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the one shot trial","volume":"139","author":"Zilli","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib27","first-page":"166","article-title":"One shot-single shot radiotherapy for localized prostate cancer: Study protocol of a single arm, multicenter phase I\/II trial","volume":"13","author":"Zilli","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1120\/jacmp.v17i6.6464","article-title":"Dosimetric comparison of intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy in patients with prostate cancer: A meta-analysis","volume":"17","author":"Ren","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1754-9485.2011.02310.x","article-title":"Dose comparisons for conformal, imrt and vmat prostate plans","volume":"55","author":"Sale","year":"2011","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijrobp.2011.09.015","article-title":"A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment","volume":"83","author":"Quan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib31","first-page":"365","article-title":"VMAT vs 7-field-IMRT: Assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample","volume":"36","author":"Kopp","year":"2011","journal-title":"Dosm"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib32","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.ijrobp.2009.03.033","article-title":"Volumetric modulated arc therapy: Planning and evaluation for prostate cancer cases","volume":"76","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.meddos.2010.06.001","article-title":"Comparison of prostate IMRT and VMAT biologically optimised treatment plans","volume":"36","author":"Hardcastle","year":"2011","journal-title":"Med Dosm"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1754-9485.2011.02324.x","article-title":"Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: A planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique","volume":"56","author":"Nguyen","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jmrs.22","article-title":"A retrospective planning analysis comparing intensity modulated radiation therapy (IMRT) to volumetric modulated arc therapy (VMAT) using two optimization algorithms for the treatment of early-stage prostate cancer","volume":"60","author":"Elith","year":"2013","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib36","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ijrobp.2010.10.024","article-title":"Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer","volume":"80","author":"Davidson","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib37","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ijrobp.2007.11.040","article-title":"Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer","volume":"71","author":"Chung","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13014-018-1059-1","article-title":"Urethra-sparing stereotactic body radiotherapy for prostate cancer: How much can the rectal wall dose be reduced with or without an endorectal balloon?","volume":"13","author":"Dubouloz","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13014-017-0822-z","article-title":"Is it possible for knowledge-based planning to improve intensity modulated radiation therapy plan quality for planners with different planning experiences in left-sided breast cancer patients?","volume":"12","author":"Wang","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib40","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1118\/1.3574874","article-title":"Knowledge-based imrt treatment planning for prostate cancer","volume":"38","author":"Chanyavanich","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib41","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ijrobp.2013.12.046","article-title":"Fully automated volumetric modulated arc therapy plan generation for prostate cancer patients","volume":"88","author":"Voet","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijrobp.2013.03.015","article-title":"A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: An example application to prostate cancer planning","volume":"87","author":"Good","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejmp.2018.08.016","article-title":"Reducing inter- and intra-planner variability in radiotherapy plan output with a commercial knowledge-based planning solution","volume":"53","author":"Scaggion","year":"2018","journal-title":"Physica Medica"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib44","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ijrobp.2017.12.276","article-title":"Improving quality and consistency in NRG Oncology Radiation Therapy Oncology Group 0631 for spine radiosurgery via knowledge-based planning","volume":"100","author":"Younge","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.002_bib45","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13014-015-0542-1","article-title":"Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans?","volume":"10","author":"Tol","year":"2015","journal-title":"Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620312426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620312426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:56:16Z","timestamp":1759744576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620312426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0360301620312426"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.002","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}